With a brief memo, Florida Surgeon General Joseph Ladapo has subverted a public health standard that’s long kept measles outbreaks under control.
invIOs’s cell therapy secures Austrian Government grant for Phase Ib trial – Pharmaceutical Technology
APN401 was developed using the cell therapy platform to target Cbl-b class of proteins, which play an inhibitory role in mediating immune response against cancer